Looking into the Crystal Ball – Where Will We Be 5 Years from Now?

8 Feb 2025 2:15 p.m. 3:45 p.m.
Brahmkamal Hall - Plenary Hall
RajkumarSharma Chair IndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow
Swetha RaniKanduri Chair United StatesOchsner Health, New Orleans, LA

Session description: Recent years have seen rapid progress in the diagnosis and treatment of kidney diseases. New therapies have been approved or are in clinical trials for various glomerular diseases and CKD. New non-invasive molecular tools are being validated for the diagnosis of kidney allograft dysfunction. Finally, re-orientation of dialysis treatment to incorporate patient preferences has gathered momentum. This session will do crystal ball gazing and forecast diagnostic and treatment scenarios for kidney diseases.
Learning objectives:
At the end of the session, the attendees will be able to understand: The rapid evolution of Glomerular Disease Diagnosis and Treatment using modern tools, and how will tools for evaluation of Kidney Allograft Dysfunction evolve using non-invasive tools.

 

Time Session
2:15 p.m.
2:30 p.m.
Evaluating Kidney Allograft Dysfunction
SK2002-001
SumitMohan Speaker United StatesColumbia University
2:30 p.m.
2:45 p.m.
Advances in Glomerular Disease Treatment
SK2002-02
JonathanBarratt Speaker United KingdomUniversity of Leicester, Leicester, UK
2:45 p.m.
3 p.m.
Risk Prediction in AKI and CKD
SK2002-03
NavdeepTangri Speaker CanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre
3 p.m.
3:15 p.m.
Prioritizing Patient-friendly Dialysis
SK2002-04
EdwinaBrown Speaker United KingdomImperial College Healthcare NHS Trust
3:15 p.m.
3:30 p.m.
Glomerular Disease Diagnostics
SK2002-01
SanjeevSethi Speaker United StatesMayo Clinic
3:30 p.m.
3:45 p.m.
Q&A
SK2002-06